First Allied Advisory Services’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

First Allied Advisory Services’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,000	Closed	-$5K	–	1265
2018 Q2	$5K	Buy	15,000 +5,000	+50%	+$4.1K	﹤0.01%	1145
2018 Q1	$15K	Hold	10,000	–	–	﹤0.01%	1160
2017 Q4	$14K	Hold	10,000	–	–	﹤0.01%	1431
2017 Q3	$23K	Buy	+10,000	New	+$13.4K	﹤0.01%	1111

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

First Allied Advisory Services's ARLZ Position: Q3 2018 in Review

First Allied Advisory Services sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 15,000 shares — an estimated $5K sold.

First Allied Advisory Services first reported a position in ARLZ in Q3 2017 and held it in 4 quarters. The position peaked at $23K in Q3 2017. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

First Allied Advisory Services reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
First Allied Advisory Services sold 15,000 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $5K.
First Allied Advisory Services first reported a position in Aralez Pharmaceuticals Inc. in Q3 2017 and held it in 4 quarters.
First Allied Advisory Services's Aralez Pharmaceuticals Inc. position peaked at $23K in Q3 2017.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on First Allied Advisory Services's 13F filing for Q3 2018, filed 14 Nov 2018.